参考文献/References:
[1] 姜睿璇,张 娟,边立衡. 2013年欧洲卒中组织关于颅内
动脉瘤及蛛网膜下腔出血的管理指南(第一部分)[J]. 中
国卒中杂志,2014,9(6):508-515.
[2] Ferguson S, Macdonald RL. Predictors of cerebral infarction
in patients with aneurysmal subarachnoid hemorrhage [J].
Neurosurgery, 2007, 60(4): 658-667.
[3] Nordestgaard BG, Varbo A. Triglycerides and cardiovascular
disease [J]. Lancet, 2014, 384(9943): 626-635.
[4] Maranh?o RC, Carvalho PO, Strunz CC, et al. Lipoprotein
(a): structure, pathophysiology and clinical implications [J].
Arq Bras Cardiol, 2014, 103(1): 76-84.
[5] Expert Panel on Detection, Evaluation, and Treatment of
High Blood Cholesterol in Adults. Executive summary of
the third report of the national cholesterol education pro-
gram (NCEP) expert panel on detection, evaluation, and
treatment of high blood cholesterol in adults (Adult
Treatment PanelⅢ) [J]. JAMA, 2001, 285(19): 2486-2497.
[6] 2014年中国胆固醇教育计划血脂异常防治建议专家组,
中华心血管病杂志编辑委员会,血脂与动脉粥样硬化循
证工作组,中华医学会心血管病学分会流行病学组.
2014年中国胆固醇教育计划血脂异常防治专家建议[J].
全科医学临床与教育,2015,(1):3-5,10.
[7] 周良辅. 现代神经外科学[M]. 复旦大学出版社,2015.
1015-1016.
[8] Bilt IA, Hasn D, Vandertop WP, et al. Impact of cardiac
complications on outcome after aneurysmal subarachnoid
hemorrhage [J]. Neurology, 2009, 22(7): 635-642.
[9] 屠传建,柳建生,宋大刚,等. 经颅多普勒对外伤性脑血管
痉挛的诊断价值 [J]. 中华创伤杂志,2011,27(3):221-
223.
[10] Tewari M, Aggarwal A, Mathuriya S, et al. The outcome
after aneurysmal sub arachnoid hemorrhage: a study of
various factors [J]. Ann Neurosci, 2015, 22(2): 78-80.
[11] Sandvei MS, Lindekleiv H, Romundstad PR, et al. Risk
factors for aneurysmal subarachnoid hemorrhage-BMI and
serum lipids: 11-year follow-up of the HUNT and the
Troms Study in Norway [J]. Acta Neurol Scand, 2012, 125
(6): 382-388.
[12] Tokuda Y, Stein GH. Serum lipids as protective factors for
subarachnoid hemorrhage [J]. J Clin Neurosci, 2005, 12(5):
538-541.
[13] Tseng MY, Hutchinson PJ, Turner CL, et al. Biological
effects of acute pravastatin treatment in patients after aneu-
rysmal subarachnoid hemorrhage: a double-blind, placebo-
controlled trial [J]. J Neurosurg, 2007, 107(6): 1092-1100.
[14] 余 秀. 阿托伐他汀防治蛛网膜下腔出血后脑血管痉挛
的临床观察[J]. 现代实用医学,2010,22(11): 1267-
1268.
[15] Sivashanmugam D, Ashish A, Anirudh S, et al. Serum lipid
profile spectrum and delayed cerebral ischemia following
subarachnoid hemorrhage: is there a relation [J]? Surg
Neuro Intern, 2015, 6(22): S543-S548.
[16] Neeraj B, David S, Amanda C, et al. Free Fatty acids and
delayed cerebral ischemia after subarachnoid hemorrhage
[J]. Stroke, 2012, 43(3): 691-696.
[17] 向定成,张金霞,阮云军,等. 冠状动脉痉挛患者血脂与血
管内皮功能的相关性研究[J]. 中国循环杂志,2006,21
(4):270-272.
[18] 吴 恳. 脑卒中患者急性期血糖、血脂浓度检测的意义
[J]. 心血管康复医学杂志,2008,17(6):544-546.
[19] 肖健青,佘杏军. 动脉粥样硬化性脑梗死患者血脂分析
[J]. 中国现代医学杂志,2006,16(22):3495-3496.
[20] Al-Tamimi YZ, Orsi NM, Quinn AC, et al. A review of de-
layed ischemic neurologic deficit following aneurysmal sub-
arachnoid hemorrhage: historical overview, current treat-
ment, and pathophysiology [J]. World Neurosurg, 2010,
73(6): 654-67.
相似文献/References:
[1]李朝晖 王玉贵 张孟超 综述 赵兴利 审校.CT灌注成像在动脉瘤性蛛网膜下腔出血中的
临床应用进展[J].中国临床神经外科杂志,2016,(05):313.[doi:10.13798/j.issn.1009-153X.2016.05.021]
[2]郭 芳 张 铭 李中振 梁恩和.动脉瘤性蛛网膜下腔出血后分流依赖性脑积水的危险因素分析[J].中国临床神经外科杂志,2016,(02):73.[doi:10.13798/j.issn.1009-153X.2016.02.004]
GUO Fang,ZHANG Ming,LI Zhong-zhen,et al.Risk factors related to shunt-dependent hydrocephalus in patients with aneurysmal subarachnoid hemorrhage[J].,2016,(11):73.[doi:10.13798/j.issn.1009-153X.2016.02.004]
[3]邹志鹏 杨 海 夏军勇 张化明 张 华 魏 恒 马江红.行血管内治疗的高龄颅内动脉瘤患者脑血管痉挛的临床分析[J].中国临床神经外科杂志,2015,(07):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
ZOU Zhi-peng,YANG Hai,XIA Jun-yong,et al.Clinical analysis of symptomatic cerebral vasospasm after endovascular treatment of ruptured cerebral aneurysms in patients of 70 and over 70 years[J].,2015,(11):401.[doi:10.13798/j.issn.1009-153X.2015.07.006]
[4]郎胜坤 许厚银 董月青 马铁柱 孙 艳 郝芊芊 王慧敏.磁共振灌注成像评估蛛网膜下腔出血后脑血管痉挛的价值[J].中国临床神经外科杂志,2016,(09):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
LANG Sheng-kuan,XU Hou-yin,DONG Yue-qing,et al.Evaluation of cerebral vasospasm after aneurysmal subarachnoid hemorrhage by magnetic resonance perfusion weighted imaging[J].,2016,(11):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
[5]潘逸珩 雷军荣 段 波 魏德胜 陈 亮 陈志明 秦 军.动脉瘤性蛛网膜下腔出血术后脑梗死的临床特点及其发生的危险因素分析[J].中国临床神经外科杂志,2017,(01):4.[doi:10.13798/j.issn.1009-153X.2017.01.002]
PAN Yi-heng,LEI Jun-rong,DUAN Bo,et al.Analysis of clinical features of postoperative cerebral infarction and the factors related to it in patients with aneurysmal subarachnoid hemorrhage[J].,2017,(11):4.[doi:10.13798/j.issn.1009-153X.2017.01.002]
[6]谢 飞 陈志远 曾家良 叶勇强.DSA联合血清SICAM-1评估颅内破裂动脉瘤术后脑血管痉挛的效果[J].中国临床神经外科杂志,2017,(09):617.[doi:10.13798/j.issn.1009-153X.2017.09.003]
XIE Fei CHEN Zhi-yuan ZENG Jia-liang,Ye Yong-qiang.Application of DSA combined with serum SICAM-1 to the evaluation of cerebral vasospasm after SAH due to aneurysmal rupture[J].,2017,(11):617.[doi:10.13798/j.issn.1009-153X.2017.09.003]
[7]阮 东 王 芳 郭丽蕊 彭红梅 陈谦学 刘宝辉.C-反应蛋白与动脉瘤性蛛网膜下腔出血临床预后的关系[J].中国临床神经外科杂志,2017,(09):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
RUAN Dong,WANG Fang,GUO Li-rui,et al.Relationship between serum level of C-reactive protein and prognoses in patients with aneurysmal subarachnoid hemorrhage[J].,2017,(11):626.[doi:10.13798/j.issn.1009-153X.2017.09.006]
[8]阿库布千、李祥龙、罗 鑫、周 江、李 昊、刘 亮、 陈礼刚、夏祥国.亚洲人群动脉瘤性蛛网膜下腔出血高压氧辅助治疗疗效的Meta分析[J].中国临床神经外科杂志,2017,(11):757.[doi:10.13798/j.issn.1009-153X.2017.11.008]
AKU Bu-qian,LI Xiang-long,LUO Xin,et al.Meta-analysis of effects of hyperbaric oxygen therapy on clinical outcomes in Asian patients with aneurysmal subarachnoid hemorrhage[J].,2017,(11):757.[doi:10.13798/j.issn.1009-153X.2017.11.008]
[9]张 兰 库洪彬 王 敏 周 燕.动脉瘤性蛛网膜下腔出血病人血清sLOX-1、netrin-1水平变化及其与病人预后的关系[J].中国临床神经外科杂志,2020,(06):377.[doi:10.13798/j.issn.1009-153X.2020.06.013]
ZHANG Lan,KU Hong-bin,WANG Min,et al.Relationship between serum levels of sLOX-1 and netrin-1 and progosis of patients with aneurysmal subarachnoid hemorrhage[J].,2020,(11):377.[doi:10.13798/j.issn.1009-153X.2020.06.013]
[10]李兵兵 洪景芳 李克磊 张 灏 张尚明 王守森.动脉瘤性蛛网膜下腔出血对脑静脉循环的影响[J].中国临床神经外科杂志,2021,26(01):17.[doi:10.13798/j.issn.1009-153X.2021.01.006]
LI Bing-bing,HONG Jing-fang,LI Ke-lei,et al.Effects of aneurysmal subarachnoid hemorrhage on cerebral venous circulation[J].,2021,26(11):17.[doi:10.13798/j.issn.1009-153X.2021.01.006]
[11]姜海洋,陈虎,郭星,等.动脉瘤性蛛网膜下腔出血病人Lindegaard比值与脑组织氧分压的相关性[J].中国临床神经外科杂志,2022,27(08):640.[doi:10.13798/j.issn.1009-153X.2022.08.005]
JIANG Hai-yang,CHEN Hu,GUO Xing,et al.Relationship between Lindegaard ratio and brain tissue oxygen tension in patients with aneurysmal subarachnoid hemorrhage[J].,2022,27(11):640.[doi:10.13798/j.issn.1009-153X.2022.08.005]
[12]付宏亮,景文记,卢俊义.血清miR-149-3p和CXCR3水平与aSAH后迟发性脑缺血的相关性分析[J].中国临床神经外科杂志,2023,28(01):11.[doi:10.13798/j.issn.1009-153X.2023.01.004]
FU Hong-liang,JING Wen-ji,LU Jun-yi.Correlation of serum levels of miR-149-3p and CXCR3 with delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage[J].,2023,28(11):11.[doi:10.13798/j.issn.1009-153X.2023.01.004]